Literatur
Jung K, Lein M, Ulbrich N et al. (1998) Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: analytical aspects. Prostate 34: 130–136
Lichtinghagen R, Musholt PB, Lein M et al. (2002) Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol 42: 398–406
Rabien A, Burkhardt M, Jung M et al. (2007) Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Eur Urol 51: 1259–1266
Takahashi C, Sheng Z, Horan TP et al. (1998) Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95: 13221–13226
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rabien, A., Jung, M., Fritzsche, F. et al. Der Tumorsuppressor RECK im Prostatakarzinom. Urologe 46, 1081–1082 (2007). https://doi.org/10.1007/s00120-007-1434-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-007-1434-2